Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve capecitabine production challenges with non-toxic alkoxycarbonylation. Avoid phosgene, reduce EHS risks, and achieve >80% yields for stable supply chains.
Overcome synthesis challenges of trisubstituted allenes with mild reaction conditions, high functional group tolerance, and 70%+ yields. Reduce supply chain risks for API manufacturing.
Discover a one-step Pd-catalyzed method for 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve heavy metal contamination in benzothiazole synthesis. Our CDMO expertise scales this visible light method with >99% purity and 98% yield for your API production.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Discover how copper-catalyzed benzofuran synthesis reduces heavy metal risks and production costs for pharmaceutical intermediates. Scale-ready solution for R&D and procurement teams.
Solve supply chain risks with this cost-effective, scalable trifluoromethyl chromonoquinoline synthesis. 99% purity, 100kgs-100MT production capacity. Contact for COA/MSDS.
Discover a cost-efficient, scalable synthesis method for furo[3,2-b]pyridine derivatives, eliminating precious metal use and reducing production costs for JAK1 inhibitor development.
Eliminate HCl gas handling and corrosion risks with EDC-NHS coupling. Achieve 92% yield and 99.7% purity for scalable betrixaban maleate production.
Solve low-yield pyranocoumarin synthesis challenges with metal-catalyzed routes. Achieve 74-98% yields, reduce environmental impact, and ensure supply chain stability for HIV/anti-estrogen drug development.
Discover a green, high-yield route for S,S-2,8-diazabicyclononane that eliminates expensive reagents and reduces waste, ensuring supply chain stability for moxifloxacin manufacturing.
Solve epimer impurity challenges in biotin production. New method achieves 99.8% conversion with 1.3% optical isomer ratio, reducing purification steps and costs.
Solve apixaban supply chain risks with this new synthesis route. Avoids toxic reagents, 88% yield, and 99.7% purity. Ideal for R&D and procurement.
Solve supply chain risks and low yields in anticancer intermediate production. Discover a 4-step, 84% yield route using common raw materials. Contact us for scalable CDMO solutions.
Discover a cost-effective, high-yield synthesis of tolvaptan intermediate with no special equipment or toxic reagents. Reduce production risks and costs for your API manufacturing.
Solve chiral synthesis challenges with 93% yield and 98:2 er. Our CDMO expertise scales this patent-protected method for stable API supply chains.
Discover a novel tadalafil synthesis method with 91.5% yield, eliminating hazardous piperonal and reducing equipment costs. Ideal for pharma R&D and procurement teams seeking scalable, eco-friendly production.
Discover how copper-catalyzed trifluoromethylation enables efficient quinazolinone synthesis for AChE/BuChE inhibition. Reduce production costs and scale complex molecules with CDMO expertise.
Solve low-yield pyrrole synthesis challenges with this novel palladium-catalyzed method. Achieve 86%+ yield using readily available materials. Contact us for scalable production.